EUVIMEDExplore EUVIMED
Leserbrief

Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution

Joao Roberto Breda iD, Brandon Masi Parker, Giselle Guerra iD, Akia Dawson, Matthias Loebe

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15020 ↗

At a glance

Leserbrief in Clinical Transplantation, 2023. Written by Joao Roberto Breda and 4 co-authors. Institution: Division of Thoracic Transplantation and Mechanical Support, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florid…. Major MEDLINE topics: COVID-19, Extracorporeal Membrane Oxygenation, Kidney Transplantation, Respiratory Insufficiency. Cited 1 times so far (Crossref); 5 references.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Several reports have shown that hospitalized kidney transplant recipients (KTR) had high mortality rates when infected with COVID‐19. Extracorporeal Membrane Oxygenation (ECMO) has been shown to be an option for refractory respiratory failure in COVID‐19 patients with variable rates of recovery. The outcome of ECMO in respiratory failure is highly related to cohort investigated and patient selection. Over a 10‐month period in the height of COVID‐19 pandemic 5 KTR patients were placed on ECMO with none of the patients surviving to discharge. All patients experienced multisystem organ failure (MSOF) and hematologic pathology while on ECMO. We concluded that COVID‐19 in KTR patients presents with a refractory MSOF that is not well supported with ECMO in a traditional approach. Future work is needed to determine how to best support refractory respiratory failure in KTR patients with COVID‐19.

Subjects

MeSH terms (MEDLINE)

COVID-19Extracorporeal Membrane OxygenationKidney TransplantationRespiratory InsufficiencyHumansPandemicsMultiple Organ FailureRetrospective Studies

Authors and institutions

  • Division of Thoracic Transplantation and Mechanical Support, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Division of Trauma and Surgical Critical Care, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Division of Kidney Transplant, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Medical Student, Ross University School of Medicine, Miramar, Florida, USA.

ORCID profiles: Joao Roberto Breda, Giselle Guerra

Cite

APA

Breda, J. R., Parker, B. M., Guerra, G., Dawson, A., & Loebe, M. (2023). Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution. Clinical Transplantation. https://doi.org/10.1111/ctr.15020

Vancouver

Breda JR, Parker BM, Guerra G, Dawson A, Loebe M. Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution. Clinical Transplantation. 2023. doi:10.1111/ctr.15020

BibTeX
@article{Breda2023,
  author = {Breda, Joao Roberto and Parker, Brandon Masi and Guerra, Giselle and Dawson, Akia and Loebe, Matthias},
  title = {Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15020}
}
Start for free →